Quadruplet regimens and antibodies for newly diagnosed multiple myeloma

Patient-Centered Care in Newly Diagnosed Multiple Myeloma: Navigating Triplet and Quadruplet TherapyПодробнее

Episode 2 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused ...Подробнее

Episode 3 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused ...Подробнее

Quadruplets vs triplets in newly diagnosed myeloma: is more better?Подробнее

GMMG-CONCEPT trial: Isa-KRd in high-risk newly diagnosed multiple myelomaПодробнее

Novel therapeutic options and quadruplet regimens for newly diagnosed multiple myelomaПодробнее

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of M...Подробнее

Integrating Quadruplet Regimens in Newly Diagnosed Multiple MyelomaПодробнее

Dr Landgren on the Management of Newly Diagnosed Multiple Myeloma TreatmentПодробнее

Integrating Quadruplet Regimens in Newly Diagnosed Multiple MyelomaПодробнее

Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MDПодробнее

Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art CareПодробнее

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and BeyondПодробнее

MRD-based response-adapted consolidation in NDMM post-transplantПодробнее

Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-FarberПодробнее

Dr. Garfall on Quadruplet Regimen in Multiple MyelomaПодробнее

Newly Diagnosed Multiple Myeloma: Quadruplet TherapyПодробнее

IMWG Conference Series: Reporting from ASH 2022Подробнее

Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art CareПодробнее

Best of 2021 ASCO & EHA WebinarПодробнее